Jean-Pierre Melun
Université de Montréal
5 Papers
Jean-Pierre Melun is an academic researcher from Université de Montréal. The author has contributed to research in topics: Prefrontal cortex & Medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue
Laurence Dion-Albert,Alice Cadoret,Ellen Doney,Fernanda Neutzling Kaufmann,Katarzyna A. Dudek,B. Daigle,Lyonna F. Parise,Flurin Cathomas,Nalia Samba,Natalie Hudson,Manon Lebel,Frederick Aardema,L. Ait Bentaleb,Janique Beauchamp,Hicham Bendahmane,Elise Benoit,Lise Bergeron,Armando Bertone,Natalie Bertrand,Félix-Antoine Bérubé,Pierre Blanchet,Janick Boissonneault,Christine J. Bolduc,Jean-Pierre Bonin,François Borgeat,Richard Burrows Angelica Boyer,Chantale Breault,Jean-Jacques Breton,Catherine Briand,Jacques Brodeur,Krystele Brule,Lyne Brunet,S. Carriere,Carine Chartrand,Rosemarie Chenard-Soucy,Tommy Chevrette,Emmanuelle Cloutier,Richard Cloutier,Hugues J. Cormier,Gilles Côté,Joanne Cyr,Pierre David,Luigi De Benedictis,Marie Claude Delisle,Patricia Deschenes,C. David Desjardins,Gilbert Desmarais,Jean-Luc Dubreucq,Mimi Dumont,Alexandre Dumais,Guylaine Ethier,Carole Feltrin,Amélie Felx,Helen Findlay,Linda Fortier,D. Fortin,Leo Fortin,Nathe François,Valerie Gagne,Marie-Pier Gagnon,Marie-Claude Gignac-Hens,Charles-Édouard Giguère,Roger Godbout,Christine Grou,Stéphane Guay,François Guillem,Najia Hachimi-Idrissi,Christophe L. Herry,Sheilah Hodgins,Saffron Homayoun,Boutheina Jemel,Christian C. Joyal,Edouard Koffi Kouassi,Réal Labelle,Denis Lafortune,Michel Lahaie,Souad Lahlafi,Pierre Lalonde,Pierre-Éric Landry,Véronique Lapaige,Guylaine Larocque,Caroline Larue,Marc E. Lavoie,Jean-Jacques Leclerc,Tania Lecomte,Cecile Lecours,Louise Leduc,Marie-France Lelan,A. Lemieux,Alain Lesage,Andrée Letarte,Jean-Luc Lepage,Alain Lévesque,Olivier Lipp,David Luck,Sonia J. Lupien,Félix-Antoine Lusignan,Richard Lusignan,André Luyet,Alykhanhthi Lynhiavu,Jean-Pierre Melun,Céline Morin,Luc Nicole,Francois Noel,Louise Normandeau,Kieron O'Connor,Christine Ouellette,Véronique Parent,Marie-Hélène Parizeau,Jean-François Pelletier,Julie Pelletier,M. J. Pelletier,Pierrich Plusquellec,Diane Poirier,Stéphane Potvin,Guylaine Prevost,Marie-Josée Prévost,Pierre Racicot,Marie-France Racine-Gagne,Patrice Renaud,Nicole Ricard,Sylvie Rivet,Michel Rolland,M Sasseville,Gabriel Safadi,Sandra Smith,Nicole Smolla,Emmanuel Stip,Jakob Teitelbaum,Alfred Thibault,Lucie Thibault,Stephanye Thibault,Frederic Thomas,Christo Todorov,Valérie Tourjman,Constantin Tranulis,Sonia Trudeau,Gilles Trudel,Nathalie Vacri,Luc Valiquette,Claude Vanier,Kathe Villeneuve,Marie-Pierre Villeneuve,Philippe D. Vincent,Marcel Wolfe,Lan Xiong,Angela Zizzi,Matthew Campbell,Gustavo Turecki,Naguib Mechawar,Caroline Menard +150 more
TL;DR: In this article , the authors reported that chronic social and subchronic variable stress promotes blood-brain barrier (BBB) alterations in mood-related brain regions of female mice.
Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings
Stéphane Potvin,Ovidiu Lungu,Olivier Lipp,Pierre Lalonde,Vessela Zaharieva,Emmanuel Stip,Jean-Pierre Melun,Adrianna Mendrek,Adrianna Mendrek +8 more
TL;DR: A key role of the brain reward system in cigarette craving in schizophrenia is highlighted, and the neurophysiologic mechanisms involved in the regulation of cue-induced cigarette craving are impaired in this population of schizophrenia smokers.
23
Allostatic load: Implications for the pathophysiology, evolution, and treatment of bipolar disorder
Anaïs DuBow,Jean-Pierre Melun,Robert-Paul Juster +2 more
- 01 Jan 2021
TL;DR: This chapter describes many of the alterations seen in the biological mediators involved in the effects of allostasis and allostatic load in bipolar disorder and the opportunities that these represent in the diagnosis, follow-up, and management of patients with this disorder.
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Sylvie Chouinard,Emmanuel Stip,Julie Poulin,Jean-Pierre Melun,Roger Godbout,François Guillem,Henri Cohen +6 more
TL;DR: Rivastigmine treatment did not appear to enhance cognition in SZ patients with important cognitive impairments, and this finding needs to be interpreted with care and requires substantiation with larger sample size studies with patients treated with cognitive enhancer for longer periods.
Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
Olivier Corbeil,Anne-Marie Essiambre,Laurent Béchard,Audrey-Anne Roy,Maxime Huot-Lavoie,Sébastien Brodeur,R Chandrasena,Chantale Thériault,Candice E. Crocker,Jean-Pierre Melun,Philip Tibbo,Marie-France Demers,Marc-André Roy +12 more
TL;DR: In this article , the authors evaluated the effectiveness of paliperidone palmitate 3-monthly (PP3M) in relapse prevention among patients with schizophrenia in a multicentre retrospective study conducted in four outpatients' clinics across Canada.